Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hammerschlag

Showing results (81-90 of 240) with videos related to

Pageof 24
Sort By:
Antimicrobial Agents and Chemotherapy|September 26, 1997
In vitro activity of trovafloxacin against Chlamydia pneumoniaeP M Roblin, A Kutlin, M R Hammerschlag
The Pediatric Infectious Disease Journal|February 7, 2023
Diagnostic Challenges of Urinary Schistosomiasis Among Adolescent Immigrants in New York City: A Report of Three CasesAsma Shaoba, Margaret R Hammerschlag, Oluwatoyin F Bamgbola
Reviews of Infectious Diseases|March 1, 1989
Epidemiology of sexually transmitted diseases in rape victimsJ B Glaser, M R Hammerschlag, W M McCormack
The Journal of Pediatrics|November 24, 2018
Caution Is Required When Using Non-Food and Drug Administration-Cleared Assays to Diagnose Sexually Transmitted Infections in ChildrenAmanda D Brownell, Robert A Shapiro, Margaret R Hammerschlag
Antimicrobial Agents and Chemotherapy|March 1, 1992
In vitro activities of five quinolones against Chlamydia pneumoniaeM R Hammerschlag, C L Hyman, P M Roblin
The Pediatric Infectious Disease Journal|January 1, 1988
False positive results with the use of chlamydial antigen detection tests in the evaluation of suspected sexual abuse in childrenM R Hammerschlag, P J Rettig, M E Shields
Journal of Clinical Microbiology|October 1, 1996
Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitroN Tsumura, U Emre, P Roblin, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniaeStephan A Kohlhoff, Michael D Huband, Margaret R Hammerschlag
Journal of Clinical Microbiology|May 1, 1994
Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell cultureG S Montalban, P M Roblin, M R Hammerschlag
The Journal of Antimicrobial Chemotherapy|September 22, 2001
Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogensM R Hammerschlag, P M Roblin, C M Bébéar
Pageof 24

Showing results (81-90 of 240) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|September 26, 1997
In vitro activity of trovafloxacin against Chlamydia pneumoniaeP M Roblin, A Kutlin, M R Hammerschlag
The Pediatric Infectious Disease Journal|February 7, 2023
Diagnostic Challenges of Urinary Schistosomiasis Among Adolescent Immigrants in New York City: A Report of Three CasesAsma Shaoba, Margaret R Hammerschlag, Oluwatoyin F Bamgbola
Reviews of Infectious Diseases|March 1, 1989
Epidemiology of sexually transmitted diseases in rape victimsJ B Glaser, M R Hammerschlag, W M McCormack
The Journal of Pediatrics|November 24, 2018
Caution Is Required When Using Non-Food and Drug Administration-Cleared Assays to Diagnose Sexually Transmitted Infections in ChildrenAmanda D Brownell, Robert A Shapiro, Margaret R Hammerschlag
Antimicrobial Agents and Chemotherapy|March 1, 1992
In vitro activities of five quinolones against Chlamydia pneumoniaeM R Hammerschlag, C L Hyman, P M Roblin
The Pediatric Infectious Disease Journal|January 1, 1988
False positive results with the use of chlamydial antigen detection tests in the evaluation of suspected sexual abuse in childrenM R Hammerschlag, P J Rettig, M E Shields
Journal of Clinical Microbiology|October 1, 1996
Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitroN Tsumura, U Emre, P Roblin, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniaeStephan A Kohlhoff, Michael D Huband, Margaret R Hammerschlag
Journal of Clinical Microbiology|May 1, 1994
Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell cultureG S Montalban, P M Roblin, M R Hammerschlag
The Journal of Antimicrobial Chemotherapy|September 22, 2001
Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogensM R Hammerschlag, P M Roblin, C M Bébéar
Pageof 24